Search

Author/Creator Cavo, M.

11. P893: CARFILZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (KRD) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS: ITALIAN, MULTICENTER, RETROSPECTIVE EXPERIENCE OUTSIDE OF CLINICAL TRIALS. (23rd June 2022)

Authors:
Martino, E. A.; Conticello, C.; Zamagni, E.; Pavone, V.; Palmieri, S.; Musso, M.; Tacchetti, P.; Mele, A.; Catlano, L.; Vigna, E.; Bruzzese, A.; Mendicino, F.; Botta, C.; Vincelli, D.; Farina, G.; Barone, M.; Cangialosi, C.; Mancuso, K.; Rizziello, I.; Rocchi, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
784
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. P932: ON-DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G-CSF FOR HEMATOPOIETIC STEM-CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY. (23rd June 2022)

Authors:
Mina, R.; Bonello, F.; Fazio, F.; Saccardi, R.; Bongarzoni, V.; Marchesi, F.; Bertuglia, G.; Curci, P.; Lemoli, R. M.; Ballanti, S.; Dentamaro, T.; Benevolo, G.; Capra, A.; Floris, R.; Tosi, P.; Olivieri, A.; Rota-Scalabrini, D.; Cangialosi, C.; Cavo, M.; Corradini, P.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
822
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA. (23rd June 2022)

Authors:
Usmani, S. Z.; Mielnik, M.; Koh, Y.; Alonso Alonso, A.; Leleu, X.; Quach, H.; Min, C.-K.; Janowski, W.; Abdallah, A.-O.; Garg, M.; Sandhu, I.; Ocio San Miguel, E. M.; Oriol, A.; Rodriquez-Otero, P.; Ramasamy, K.; Weisel, K.; Besemer, B.; Cavo, M.; Zhou, X. L.; Kaisermann, M. C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
832
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. P993: SETD2 IS A BONA FIDE TUMOR SUPPRESSOR IN SYSTEMIC MASTOCYTOSIS. (23rd June 2022)

Authors:
Mancini, M.; Monaldi, C.; De Santis, S.; Papayannidis, C.; Rondoni, M.; Sartor, C.; Bruno, S.; Curti, A.; Zanotti, R.; Bonifacio, M.; Scaffidi, L.; Pagano, L.; Criscuolo, M.; Ciceri, F.; Elena, C.; Tosi, P.; Valent, P.; Cavo, M.; Soverini, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
883
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3-YEAR FOLLOW-UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLLED CLINICAL TRIALS. (23rd June 2022)

Authors:
Bruzzese, A.; Derudas, D.; Galli, M.; Martino, E. A.; Rocco, S.; Conticello, C.; Califano, C.; Giuliani, N.; Mangicavalli, S.; Farina, G.; Lombardo, A.; Brunori, M.; Rossi, E.; Antonioli, E.; Ria, R.; Zambello, R.; Di Renzo, N.; Mele, G.; Marcacci, G.; Pietrantuono, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1856
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. PB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA. (23rd June 2022)

Authors:
Delimpasi, S.; Quach, H.; Cavo, M.; Ho, P. J.; Lee, C. H.-S.; Santoro, A.; Schots, R.; Vlummens, P.; Yoon, D. H.; Yoon, S.-S.; Santos, C. D.; Samineni, D.; Huang, J.; Wehrman, K.; Patil, U.; Sheikh, S.; Dimopoulos, M. A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1906
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension. (8th April 2019)

Authors:
Bringhen, S.; Milan, A.; D'Agostino, M.; Ferri, C.; Wäsch, R.; Gay, F.; Larocca, A.; Offidani, M.; Zweegman, S.; Terpos, E.; Goldschmidt, H.; Cavo, M.; Ludwig, H.; Driessen, C.; Auner, H. W.; Caers, J.; Gramatzki, M.; Dimopoulos, M. A.; Boccadoro, M.; Einsele, H.
Journal:
Journal of internal medicine
Issue:
Volume 286:Number 1(2019)
Page Start:
63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. S152: SETD2/H3K36ME3 DEFICIENCY SUSTAINS GENOMIC INSTABILITY AND ENHANCES CLONOGENIC POTENTIAL OF CHRONIC MYELOID LEUKEMIA (CML) PROGENITORS. (23rd June 2022)

Authors:
Mancini, M.; De Santis, S.; Monaldi, C.; Bruno, S.; Castagnetti, F.; Gugliotta, G.; Iurlo, A.; Cerrano, M.; Galimberti, S.; Balducci, S.; Stagno, F.; Rosti, G.; Cavo, M.; Soverini, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. S174: HIGH LEVEL OF CIRCULATING TUMOUR DNA AT DIAGNOSIS CORRELATES WITH DISEASE SPREADING AND DEFINES MULTIPLE MYELOMA PATIENTS WITH POOR PROGNOSIS. (23rd June 2022)

Authors:
Martello, M.; Poletti, A.; Bezzi, D.; Borsi, E.; Taurisano, B.; Solli, V.; Armuzzi, S.; Vigliotta, I.; Mazzocchetti, G.; Pistis, I.; Pantani, L.; Rocchi, S.; Mancuso, K.; Tacchetti, P.; Rizzello, I.; Cavo, M.; Zamagni, E.; Nanni, C.; Terragna, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
75
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

20. S184: EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA FOLLOWING EXPOSURE TO OTHER B-CELL MATURATION ANTIGEN (BCMA)-TARGETED AGENTS. (23rd June 2022)

Authors:
Touzeau, C.; Krishnan, A.; Moreau, P.; Perrot, A.; Usmani, S. Z.; Manier, S.; Cavo, M.; Martinez-Chamorro, C.; Nooka, A.; Martin, T.; Karlin, L.; Leleu, X.; Bahlis, N.; Besemer, B.; Pei, L.; Verona, R.; Girgis, S.; Uhlar, C.; Kobos, R.; Garfall, A.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
85
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗